From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension

Frontiers in Physiology

Volumn 5 JUN, Issue , 2014, Pages

  Patel, Sheila K ^a   Velkoska, Elena ^a   Freeman, Melanie ^a   Wai, Bryan ^a   Lancefield, Terase F ^a   Burrell, Louise M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme; Angiotensin converting enzyme 2; Blood pressure; Hypertension; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2;

ACE2 GENE; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; GENE DELETION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; NONHUMAN; POTASSIUM INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM INTAKE; TREATMENT RESPONSE;

EID: 84904431923     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00227     Document Type: Article

References (102)

1. Bai, S., Huang, Z. G., Chen, L., Wang, J. T., and Ding, B. P. (2013). Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat. Regul. Pept. 184, 54-61. doi: 10.1016/j.regpep.2013.03.005
2. Benjafield, A. V., Wang, W. Y., and Morris, B. J. (2004). No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. Am. J. Hypertens. 17, 624-628. doi: 10.1016/j.amjhyper.2004.02.022
3. Burchill, L., Velkoska, E., Dean, R. G., Lew, R. A., Smith, A. I., Levidiotis, V., et al. (2008). Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp. Physiol. 93, 622-630. doi: 10.1113/expphysiol.2007.040386
4. Burgelova, M., Vanourkova, Z., Thumova, M., Dvorak, P., Opocensky, M., Kramer, H. J., et al. (2009). Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J. Hypertens. 27, 1988-2000. doi: 10.1097/HJH.0b013e32832f0d06
5. Burrell, L. M., Burchill, L., Dean, R. G., Griggs, K., Patel, S. K., and Velkoska, E. (2012). Chronic kidney disease: cardiac and renal angiotensin converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Exp. Physiol. 97, 477-485. doi: 10.1113/expphysiol.2011.063156
6. Burrell, L. M., Harrap, S. B., Velkoska, E., and Patel, S. K. (2013). The ACE2 gene: its potential as a functional candidate for cardiovascular disease. Clin. Sci. (Lond.) 124, 65-76. doi: 10.1042/CS20120269
7. Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., et al. (2005). Myocardial infarction increases ACE2 expression in rat and humans. Eur. Heart J. 26, 369-375. doi: 10.1093/eurheartj/ehi114
8. Chong, C. P., Lim, W. K., Velkoska, E., van Gaal, W. J., Ryan, J. E., Savige, J., et al. (2012). N-terminal pro-brain natriuretic peptide and angiotension converting enzyme 2 levels and their association with post-operative cardiac complications after emergency orthopaedic surgery. Am. J. Cardiol. 109, 1365-1373. doi: 10.1016/j.amjcard.2011.12.032
9. Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., et al. (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417, 822-828. doi: 10.1038/nature00786
10. Dales, N. A., Gould, A. E., Brown, J. A., Calderwood, E. F., Guan, B., Minor, C. A., et al. (2002). Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 124, 11852-11853. doi: 10.1021/ja0277226
11. Diez-Freire, C., Vazquez, J., Correa de Adjounian, M. F., Ferrari, M. F., Yuan, L., Silver, X., et al. (2006). ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol. Genomics 27, 12-19. doi: 10.1152/physiolgenomics.00312.2005
12. Dilauro, M., Zimpelmann, J., Robertson, S. J., Genest, D., and Burns, K. D. (2010). The effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am. J. Physiol. Renal Physiol. 298, F1523-F1532. doi: 10.1152/ajprenal.00426.2009
13. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., et al. (2000). A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, E1-E9. doi: 10.1161/01.RES.87.5.e1
14. Doobay, M. F., Talman, L. S., Obr, T. D., Tian, X., Davisson, R. L., and Lazartigues, E. (2007). Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R373-R381. doi: 10.1152/ajpregu.00292.2006
15. Dzau, V. (2005). The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J. Hypertens. Suppl. 23, S9-S17. doi: 10.1097/01.hjh.0000165623.72310.dd
16. Fan, X., Wang, Y., Sun, K., Zhang, W., Yang, X., Wang, S., et al. (2007). Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. Clin. Pharmacol. Ther. 82, 187-196. doi: 10.1038/sj.clpt.6100214
17. Fan, X. H., Wang, Y. B., Wang, H., Sun, K., Zhang, W. L., Song, X. D., et al. (2009). Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients. Acta Pharmacol. Sin. 30, 1237-1244. doi: 10.1038/aps.2009.110
18. Ferreira, A. J., Shenoy, V., Qi, Y., Fraga-Silva, R. A., Santos, R. A., Katovich, M. J., et al. (2011). Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Exp. Physiol. 96, 287-294. doi: 10.1113/expphysiol.2010.055277
19. Freeman, M., Patel, S. K., Lancefield, T., Velkoska, E., Griggs, K., Dean, R. G., et al. (2011). Angiotensin converting enzyme 2: a novel marker of coronary artery disease. Eur. Heart J. 31, 515.
20. Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., et al. (2006). Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Invest. 116, 2218-2225. doi: 10.1172/JCI16980
21. Haber, P. K., Ye, M., Wysocki, J., Maier, C., Haque, S. K., and Batlle, D. (2014). Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro. Hypertension 63, 774-782. doi: 10.1161/HYPERTENSIONAHA.113.02856
22. Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., et al. (2013). Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin. Pharmacokinet. 52, 783-792. doi: 10.1007/s40262-013-0072-7
23. Hernandez Prada, J. A., Ferreira, A. J., Katovich, M. J., Shenoy, V., Qi, Y., Santos, R. A., et al. (2008). Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 51, 1312-1317. doi: 10.1161/HYPERTENSIONAHA.107.108944
24. Huang, J., Chen, S., Lu, X., Zhao, Q., Rao, D. C., Jaquish, C. E., et al. (2012). Polymorphisms of ACE2 are associated with blood pressure response to cold pressor test: the GenSalt study. Am. J. Hypertens. 25, 937-942. doi: 10.1038/ajh.2012.61
25. Huang, W., Yang, W., Wang, Y., Zhao, Q., Gu, D., and Chen, R. (2006). Association study of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms and essential hypertension in northern Han Chinese. J. Hum. Hypertens. 20, 968-971. doi: 10.1038/sj.jhh.1002090
26. Huentelman, M. J., Grobe, J. L., Vazquez, J., Stewart, J. M., Mecca, A. P., Katovich, M. J., et al. (2005). Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp. Physiol. 90, 783-790. doi: 10.1113/expphysiol.2005.031096
27. Johnston, C. I. (1994). Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23, 258-268. doi: 10.1161/01.HYP.23.2.258
28. Kamilic, J., Hamming, I., Kreutz, R., Bolbrinker, J., Siems, W. E., Nassar, I., et al. (2010). Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27. Hypertens. Res. 33, 123-128. doi: 10.1038/hr.2009.191
29. Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., and He, J. (2005). Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223. doi: 10.1016/S0140-6736(05)17741-1
30. Keidar, S., Strizevsky, A., Raz, A., and Gamliel-Lazarovich, A. (2007). ACE2 activity is increased in monocyte-derived macrophages from prehypertensive subjects. Nephrol. Dial. Transplant 22, 597-601. doi: 10.1093/ndt/gfl632
31. Kulemina, L. V., and Ostrov, D. A. (2011). Prediction of off-target effects on angiotensin-converting enzyme 2. J. Biomol. Screen. 16, 878-885. doi: 10.1177/1087057111413919
32. Lambert, D. W., Clarke, N. E., Hooper, N. M., and Turner, A. J. (2008). Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett. 582, 385-390. doi: 10.1016/j.febslet.2007.11.085
33. Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., et al. (2005). Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113-30119. doi: 10.1074/jbc.M505111200
34. Landau, D., Chayat, C., Zucker, N., Golomb, E., Yagil, C., Yagil, Y., et al. (2008). Early blood pressure-independent cardiac changes in diabetic rats. J. Endocrinol. 197, 75-83. doi: 10.1677/JOE-08-0040
35. Lemarie, C. A., and Schiffrin, E. L. (2010). The angiotensin II type 2 receptor in cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 11, 19-31. doi: 10.1177/1470320309347785
36. Lew, R. A., Warner, F. J., Hanchapola, I., Yarski, M. A., Manohar, J., Burrell, L. M., et al. (2008). Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Exp. Physiol. 93, 685-693. doi: 10.1113/expphysiol.2007.040352
37. Lieb, W., Graf, J., Gotz, A., Konig, I. R., Mayer, B., Fischer, M., et al. (2006). Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J. Mol. Med. 84, 88-96. doi: 10.1007/s00109-005-0718-5
38. Lo, J., Patel, V. B., Wang, Z., Levasseur, J., Kaufman, S., Penninger, J. M., et al. (2013). Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats. Exp. Physiol. 98, 109-122. doi: 10.1113/expphysiol.2012.067165
39. Lu, N., Yang, Y., Wang, Y., Liu, Y., Fu, G., Chen, D., et al. (2012). ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects. Mol. Biol. Rep. 39, 6581-6589. doi: 10.1007/s11033-012-1487-1
40. Malard, L., Kakinami, L., O'Loughlin, J., Roy-Gagnon, M. H., Labbe, A., Pilote, L., et al. (2013). The association between the Angiotensin-Converting Enzyme-2 gene and blood pressure in a cohort study of adolescents. BMC Med. Genet. 14:117. doi: 10.1186/1471-2350-14-117
41. Martins Lima, A., Xavier, C. H., Ferreira, A. J., Raizada, M. K., Wallukat, G., Velloso, E. P., et al. (2013). Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress. Am. J. Physiol. Heart Circ. Physiol. 305, H1057-H1067. doi: 10.1152/ajpheart.00433.2013
42. McCarthy, C. A., Widdop, R. E., Denton, K. M., and Jones, E. S. (2013). Update on the angiotensin AT(2) receptor. Curr. Hypertens. Rep. 15, 25-30. doi: 10.1007/s11906-012-0321-4
43. Meng, W., Zhao, W., Zhao, T., Liu, C., Chen, Y., Liu, H., et al. (2014). Autocrine and paracrine function of angiotensin 1-7 in tissue repair during hypertension. Am. J. Hypertens. 27, 775-782. doi: 10.1093/ajh/hpt270
44. Mizuiri, S., Hemmi, H., Arita, M., Ohashi, Y., Tanaka, Y., Miyagi, M., et al. (2008). Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am. J. Kidney Dis. 51, 613-623. doi: 10.1053/j.ajkd.2007.11.022
45. Niu, W., Qi, Y., Hou, S., Zhou, W., and Qiu, C. (2007). Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Transl. Res. 150, 374-380. doi: 10.1016/j.trsl.2007.06.002
46. Ocaranza, M. P., Rivera, P., Novoa, U., Pinto, M., Gonzalez, L., Chiong, M., et al. (2011). Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension. J. Hypertens. 29, 706-715. doi: 10.1097/HJH.0b013e3283440665
47. Ohtsuki, M., Morimoto, S., Izawa, H., Ismail, T. F., Ishibashi-Ueda, H., Kato, Y., et al. (2010). Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure. Int. J. Cardiol. 145, 333-334. doi: 10.1016/j.ijcard.2009.11.057
48. Ortiz-Perez, J. T., Riera, M., Bosch, X., De Caralt, T. M., Perea, R. J., Pascual, J., et al. (2013). Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PLoS ONE 8:e61695. doi: 10.1371/journal.pone.0061695
49. Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., et al. (2010). Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59, 529-538. doi: 10.2337/db09-1218
50. Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., et al. (2005). Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54, 1790-1796. doi: 10.1136/gut.2004.062398
51. Patel, S. K., Velkoska, E., and Burrell, L. M. (2013b). Emerging markers in cardiovascular disease: where does angiotensin-converting enzyme 2 fit in? Clin. Exp. Pharmacol. Physiol. 40, 551-559. doi: 10.1111/1440-1681.12069
52. Patel, S. K., Wai, B., Ord, M., Macisaac, R. J., Grant, S., Velkoska, E., et al. (2012). Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes. Am. J. Hypertens. 25, 216-222. doi: 10.1038/ajh.2011.188
53. Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R., et al. (2013a). Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. J. Mol. Cell. Cardiol. 66, 167-176. doi: 10.1016/j.yjmcc.2013.11.017
54. Patnaik, M., Pati, P., Swain, S. N., Mohapatra, M. K., Dwibedi, B., Kar, S. K., et al. (2014). Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India. Ann. Hum. Biol. 41, 143-150. doi: 10.3109/03014460.2013.837195
55. Pendergrass, K. D., Pirro, N. T., Westwood, B. M., Ferrario, C. M., Brosnihan, K. B., and Chappell, M. C. (2008). Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats. Am. J. Physiol. Heart Circ. Physiol. 295, H10-H20. doi: 10.1152/ajpheart.01277.2007
56. Prieto, M. C., Gonzalez-Villalobos, R. A., Botros, F. T., Martin, V. L., Pagan, J., Sato, R., et al. (2011). Reciprocal changes in renal ACE/Ang II and ACE2/Ang 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am. J. Physiol. Renal Physiol. 300, F749-F755. doi: 10.1152/ajprenal.00383.2009
57. Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W., and Herzenberg, A. M. (2008). Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610-1616. doi: 10.1038/ki.2008.497
58. Rentzsch, B., Todiras, M., Iliescu, R., Popova, E., Campos, L. A., Oliveira, M. L., et al. (2008). Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52, 967-973. doi: 10.1161/HYPERTENSIONAHA.108.114322
59. Rice, G. I., Jones, A. L., Grant, P. J., Carter, A. M., Turner, A. J., and Hooper, N. M. (2006). Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension 48, 914-920. doi: 10.1161/01.HYP.0000244543.91937.79
60. Roberts, M. A., Velkoska, E., Ierino, F. L., and Burrell, L. M. (2013). Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease. Nephrol. Dial. Transplant 28, 2287-2294. doi: 10.1093/ndt/gft038
61. Santiago, N. M., Guimaraes, P. S., Sirvente, R. A., Oliveira, L. A., Irigoyen, M. C., and Santos, R. A. (2010). Campagnole-Santos, MJ. Lifetime overproduction of circulating angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling. Hypertension 55, 889-96. doi: 10.1161/HYPERTENSIONAHA.110.149815
62. Santos, R. A. (2014). Angiotensin-(1-7). Hypertension 63, 1138-1147. doi: 10.1161/HYPERTENSIONAHA.113.01274
63. Santos, R. A., Simoese Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., et al. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263. doi: 10.1073/pnas.1432869100
64. Shiota, A., Yamamoto, K., Ohishi, M., Tatara, Y., Ohnishi, M., Maekawa, Y., et al. (2010). Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertens. Res. 33, 298-307. doi: 10.1038/hr.2009.231
65. Sluimer, J. C., Gasc, J. M., Hamming, I., van Goor, H., Michaud, A., van den Akker, L. H., et al. (2008). Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol. 215, 273-279. doi: 10.1002/path.2357
66. Song, S. B., Jin, H. S., Hong, K. W., Lim, J. E., Moon, J. Y., Jeong, K. H., et al. (2011). Association between renin-angiotensin-aldosterone system-related genes and blood pressure in a Korean population. Blood Press. 20, 204-210. doi: 10.3109/08037051.2011.555074
67. Soro-Paavonen, A., Gordin, D., Forsblom, C., Rosengard-Barlund, M., Waden, J., Thorn, L., et al. (2012). Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 30, 375-383. doi: 10.1097/HJH.0b013e32834f04b6
68. Sriramula, S., Cardinale, J. P., Lazartigues, E., and Francis, J. (2011). ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc. Res. 92, 401-408. doi: 10.1093/cvr/cvr242
69. Takeda, Y., Zhu, A., Yoneda, T., Usukura, M., Takata, H., and Yamagishi, M. (2007). Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Am. J. Hypertens. 20, 1119-1124. doi: 10.1016/j.amjhyper.2007.05.008
70. Tallant, E. A., and Clark, M. A. (2003). Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42, 574-579. doi: 10.1161/01.HYP.0000090322.55782.30
71. Tan, Z., Wu, J., and Ma, H. (2011). Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats. J. Renin Angiotensin Aldosterone Syst. 12, 413-419. doi: 10.1177/1470320311402109
72. Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Su, Q., Johnston, C., et al. (2008). ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 57, 1018-1025. doi: 10.2337/db07-1212
73. Tikellis, C., Cooper, M. E., Bialkowski, K., Johnston, C. I., Burns, W. C., Lew, R. A., et al. (2006). Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int. 70, 34-41. doi: 10.1038/sj.ki.5000428
74. Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., et al. (2003). Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41, 392-397. doi: 10.1161/01.HYP.0000060689.38912.CB
75. Tikellis, C., Pickering, R., Tsorotes, D., Du, X. J., Kiriazis, H., Nguyen-Huu, T. P., et al. (2012). Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes. Clin. Sci. (Lond.) 123, 519-529. doi: 10.1042/CS20110668
76. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., and Turner, A. J. (2000). A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238-33243. doi: 10.1074/jbc.M002615200
77. Trask, A. J., Groban, L., Westwood, B. M., Varagic, J., Ganten, D., Gallagher, P. E., et al. (2010). Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. Am. J. Hypertens. 23, 687-693. doi: 10.1038/ajh.2010.51
78. Uri, K., Fagyas, M., Manyine Siket, I., Kertesz, A., Csanadi, Z., Sandorfi, G., et al. (2014). New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS ONE 9:e87845. doi: 10.1371/journal.pone.0087845
79. Varagic, J., Ahmad, S., Brosnihan, K. B., Groban, L., Chappell, M. C., Tallant, E. A., et al. (2010). Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction. Ther. Adv. Cardiovasc. Dis. 4, 17-25. doi: 10.1177/1753944709353337
80. Varagic, J., Ahmad, S., Voncannon, J. L., Moniwa, N., Simington, S. W. Jr., Brosnihan, B. K., et al. (2012). Nebivolol reduces cardiac angiotensin II, associated oxidative stress and fibrosis but not arterial pressure in salt-loaded spontaneously hypertensive rats. J. Hypertens. 30, 1766-1774. doi: 10.1097/HJH.0b013e328356766f
81. Velkoska, E., Dean, R. G., Burchill, L., Levidiotis, V., and Burrell, L. M. (2010). Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition. Clin. Sci. (Lond.) 118, 269-279. doi: 10.1042/CS20090318
82. Velkoska, E., Dean, R. G., Griggs, K., Burchill, L., and Burrell, L. M. (2011). Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clin. Sci. (Lond.) 120, 335-345. doi: 10.1042/CS20100280
83. Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., et al. (2002). Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277, 14838-14843. doi: 10.1074/jbc.M200581200
84. World Health Organization. (2011). Global Atlas on Cardiovascular Disease Prevention and Control. eds S. Mendis, P. Puska, and B. Norrving (Geneva: World Health Organization).
85. Wysocki, J., Ye, M., Rodriguez, E., Gonzalez-Pacheco, F. R., Barrios, C., Evora, K., et al. (2010). Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 55, 90-98. doi: 10.1161/HYPERTENSIONAHA.109.138420
86. Xia, H., Feng, Y., Obr, T. D., Hickman, P. J., and Lazartigues, E. (2009). Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension 53, 210-216. doi: 10.1161/HYPERTENSIONAHA.108.123844
87. Xia, H., Sriramula, S., Chhabra, K. H., and Lazartigues, E. (2013). Brain ACE2 shedding contributes to the development of neurogenic hypertension. Circ. Res. 113, 1087-1096. doi: 10.1161/CIRCRESAHA.113.301811
88. Xu, P., Sriramula, S., and Lazartigues, E. (2011). ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R804-R817. doi: 10.1152/ajpregu.00222.2010
89. Yagil, Y., and Yagil, C. (2003). Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 41, 871-873. doi: 10.1161/01.HYP.0000063886.71596.C8
90. Yamazato, M., Yamazato, Y., Sun, C., Diez-Freire, C., and Raizada, M. K. (2007). Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49, 926-931. doi: 10.1161/01.HYP.0000259942.38108.20
91. Yang, Z., Yu, X., Cheng, L., Miao, L.-Y., Li, H.-X., Han, L.-H., et al. (2013). Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats. Arch. Cardiovasc. Dis. 106, 196-201. doi: 10.1016/j.acvd.2013.01.004
92. Ye, M., Wysocki, J., Gonzalez-Pacheco, F. R., Salem, M., Evora, K., Garcia-Halpin, L., et al. (2012). Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60, 730-740. doi: 10.1161/HYPERTENSIONAHA.112.198622
93. Yi, L., Gu, Y. H., Wang, X. L., An, L. Z., Xie, X. D., Shao, W., et al. (2006). Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J. Int. Med. Res. 34, 272-283. doi: 10.1177/147323000603400306
94. Zhao, Q., Gu, D., Kelly, T. N., Hixson, J. E., Rao, D. C., Jaquish, C. E., et al. (2010a). Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. Am. J. Hypertens. 23, 606-613. doi: 10.1038/ajh.2010.36
95. Zhao, Q., Hixson, J. E., Rao, D. C., Gu, D., Jaquish, C. E., Rice, T., et al. (2010b). Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study. J. Hypertens. 28, 756-763. doi: 10.1097/HJH.0b013e3283370d32
96. Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., et al. (2010). Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122, 717-728. doi: 10.1161/CIRCULATIONAHA.110.955369
97. Zhong, J., Guo, D., Chen, C. B., Wang, W., Schuster, M., Loibner, H., et al. (2011). Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 57, 314-322. doi: 10.1161/HYPERTENSIONAHA.110.164244
98. Zhong, J., Yan, Z., Liu, D., Ni, Y., Zhao, Z., Zhu, S., et al. (2006). Association of angiotensin-converting enzyme 2 gene A/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome. J. Lab. Clin. Med. 147, 91-95. doi: 10.1016/j.lab.2005.10.001
99. Zhong, J. C., Huang, D. Y., Yang, Y. M., Li, Y. F., Liu, G. F., Song, X. H., et al. (2004). Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44, 907-912. doi: 10.1161/01.HYP.0000146400.57221.74
100. Zhou, J. B., and Yang, J. K. (2009). Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension. J. Renin Angiotensin Aldosterone Syst. 10, 31-34. doi: 10.1177/1470320309103047
101. Zulli, A., Burrell, L. M., Buxton, B. F., and Hare, D. L. (2008). ACE2 and AT4R are present in diseased human blood vessels. Eur. J. Histochem. 52, 39-44.
102. Zulli, A., Burrell, L. M., Widdop, R. E., Black, M. J., Buxton, B. F., and Hare, D. L. (2006). Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques. J. Histochem. Cytochem. 54, 147-150. doi: 10.1369/jhc.5C6782.2005